How Big Pharmas Simultaneously Repel And Embrace Innovation

How Big Pharmas Simultaneously Repel And Embrace Innovation

Source: 
Forbes
snippet: 

This dual-nature of pharma innovation may explain both why so many innovators are repelled by large pharma companies, yet some – including those focused on digital and data – are deliberately seeking out opportunities in these corporations.

In contrast to big drug companies, the appeal of startups is easy to understand – the self-actualization, the sense that your individual contribution not only matters but is essential, the feeling of David vs Goliath, the allure of significant upside, both in terms of impact (disruption, making the world a better place, etc.) and financial return.